Keyword: Takeda


Novartis Divests Ophthalmology Assets to Bausch + Lomb for Up to $2.5 Billion

03.07.2023 -

Novartis has signed an agreement to divest its 'front of eye' ophthalmology assets to Bausch + Lomb, a global eye health company. The transaction is valued at up to $2.5...


Takeda Plans New Plant for Plasma-derived Therapies

30.03.2023 -

Japanese drugmaker Takeda plans to invest about $765 million to build a new manufacturing facility in Osaka for plasma-derived therapies (PDTs). The company said the sum...


Takeda Takes Nimbus Lakshmi for $4 Billion

16.12.2022 -

Japanese pharma Takeda is acquiring Nimbus Lakshmi, a wholly-owned subsidiary of US clinical-stage drug discovery company Nimbus Therapeutics, and its tyrosine kinase 2...


Takeda is Overall Winner of ISPE’s 2022 Facility of the Year Awards

11.11.2022 -

The International Society for Pharmaceutical Engineering (ISPE) has announced Takeda Pharmaceuticals International as the 2022 Facility of the Year Awards (FOYA) Overall...


Takeda Takes GammaDelta Therapeutics

02.11.2021 -

Following a multi-year collaboration, Japanese pharma Takeda has exercised its option to buy the UK’s GammaDelta Therapeutics for a pre-negotiated upfront sum, as well as...


Japan Orders 150 Million Takeda-made Novavax Doses

13.09.2021 -

Japanese drugmaker Takeda has clarified its plans to produce and distribute the Novavax Covid-19 shot in the country, if and when it is approved. After several delays, in...

Strategy & Management

A Roadmap for Pharma 4.0

07.09.2021 -

Industry experts Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 group – talk about the idea behind ISPE’s Pharma...


Rovi Says Particles in Moderna Vials Were Metal Splinters

02.09.2021 -

The question of what kind of particulate matter found its way into vials of Moderna’s Covid-19 vaccine deployed in Japan may have been resolved. There is as yet...